Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: IMPACT OF GERIATRIC ASSESSMENT AND SOMATIC MUTATIONS IN HIGH-RISK MYELODYSPLASTIC SYNDROMES NOT ELIGIBLE FOR ALO-HCST. CET-AZA-2016–1 2022 UPDATE. ON BEHALF OF THE CETLAM GROUP

Autor:	N. Amer, M. Cabezón, B. Xicoy, A. Garrido, N. Baena, M. Canet, M. Arnan, L. Arenillas, R. Coll, X. Ortin, M. Diaz, C. Talarn, M. García-Caro, L. Zamora, J. Bargay
Rok vydání:	2023
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Leukemia Research. 128:107221
ISSN:	0145-2126
DOI:	10.1016/j.leukres.2023.107221
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6e777b66c455d8e98dc22d2fb7822f35 https://doi.org/10.1016/j.leukres.2023.107221 Zobrazit plný text záznamu Full Text from ScienceDirect